The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seo, S. K.
Right arrow Articles by Kwon, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seo, S. K.
Right arrow Articles by Kwon, B. S.
The Journal of Immunology, 2003, 171: 576-583.
Copyright © 2003 by The American Association of Immunologists

Blocking 4-1BB/4-1BB Ligand Interactions Prevents Herpetic Stromal Keratitis1

Su K. Seo*, Hye Y. Park*, Jae H. Choi*, Won Y. Kim*, Young H. Kim*, Hyo W. Jung*, Byungsuk Kwon*, Hyeon W. Lee* and Byoung S. Kwon2,*,{dagger}

* Immunomodulation Research Center, University of Ulsan, Ulsan, Korea; and {dagger} Louisiana State University Eye Center, Louisiana State University Health Sciences Center School of Medicine, New Orleans, LA 70112

Herpetic stromal keratitis (HSK) is a chronic inflammatory process in corneal stroma that results from recurrent HSV type 1 infection. We used the murine model of HSK to demonstrate the importance of the interaction between an inducible T cell costimulatory receptor, 4-1BB, and its ligand, 4-1BB ligand (4-1BBL), in the development of this disease. In BALB/c mice, HSK ordinarily induced by infection with the RE strain of herpes was prevented by blocking 4-1BB/4-1BBL interaction, either by deleting 4-1BB (in mutant 4-1BB-/- mice) or by introducing mAbs against 4-1BBL. The majority of T cells infiltrating the infected corneas were 4-1BB+ activated effector cells that expressed cell surface markers CD44, CD25, and/or CD62L, as well as chemokine receptors CCR1, CCR2, and CCR5, and a limited number of TCR V{beta} chains (V{beta}8.1/8.2, V{beta}8.3, V{beta}10b, and V{beta}5.1/5.2, in order of abundance). Analysis of cell surface phenotypes showed that the failure to develop HSK in the 4-1BB-/- mice was associated with a reduced expression of CD62L at the time of T cell migration into the corneal stroma.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
Q.-T. Nguyen, S.-A Ju, S.-M. Park, S.-C. Lee, H. Yagita, I. H. Lee, and B.-S. Kim
Blockade of CD137 Signaling Counteracts Polymicrobial Sepsis Induced by Cecal Ligation and Puncture
Infect. Immun., September 1, 2009; 77(9): 3932 - 3938.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. S. Vinay, J. D. Kim, T. Asai, B. K. Choi, and B. S. Kwon
Absence of 4 1BB Gene Function Exacerbates Lacrimal Gland Inflammation in Autoimmune-Prone MRL-Faslpr Mice
Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4608 - 4615.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Shen, Y. Jin, G. J. Freeman, A. H. Sharpe, and M. R. Dana
The Function of Donor versus Recipient Programmed Death-Ligand 1 in Corneal Allograft Survival
J. Immunol., September 15, 2007; 179(6): 3672 - 3679.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Fuse, S. Bellfy, H. Yagita, and E. J. Usherwood
CD8+ T Cell Dysfunction and Increase in Murine Gammaherpesvirus Latent Viral Burden in the Absence of 4-1BB Ligand
J. Immunol., April 15, 2007; 178(8): 5227 - 5236.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. J. Lepisto, M. Xu, H. Yagita, A. D. Weinberg, and R. L. Hendricks
Expression and function of the OX40/OX40L costimulatory pair during herpes stromal keratitis
J. Leukoc. Biol., March 1, 2007; 81(3): 766 - 774.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Dawicki, E. M. Bertram, A. H. Sharpe, and T. H. Watts
4-1BB and OX40 Act Independently to Facilitate Robust CD8 and CD4 Recall Responses
J. Immunol., November 15, 2004; 173(10): 5944 - 5951.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.